ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Three researchers share Paul Marks Prize.

November 11, 2005

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

Community Tobacco Control Intervention Grants Funded By NCI.

October 27, 2000

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000